Inside EMA: From idea to medicines: how EMA supports innovation

Inside EMA: From idea to medicines: how EMA supports innovation

How does a medicine go from a first idea to reaching patients — and what role does regulation play along the way? In this episode of Inside EMA, we explore how the European Medicines Agency (EMA) supports medicines developers throughout the entire development journey. From early scientific ideas to regulatory guidance, this conversation shows how innovation and regulation work hand in hand to deliver safe, effective medicines for patients across Europe. In this episode, we discuss: • Why pharmaceutical innovation is vital for Europe’s global competitiveness • EMA’s early dialogue platforms and how developers can receive scientific and regulatory guidance • Incentives and tailored support available for small and medium-sized enterprises (SMEs) • EMA’s proactive engagement with innovation hubs, technology transfer offices, and biotech clusters Speakers: • Emmanuel Cormier, Head of Regulatory Science and Innovation • Alessandro Faia, Communications Officer Learn more: Opportunities to interact with EMA during the development of a medicine [https://www.ema.europa.eu/en/human-regulatory-overview/research-development#opportunities-to-interact-with-ema-during-the-development-of-a-medicine-38736]